SCHEMBL4739377

SCHEMBL4739377

CN(C)C(CCO)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.44
BRD4 O60885 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
OPRM1 P35372 1/20 0.39
CHRM2 P08172 2/20 0.39
CHRM5 P08912 2/20 0.39
CHRM1 P11229 2/20 0.39
ADRA2B P18089 2/20 0.39
SLC6A2 P23975 2/20 0.39
HRH2 P25021 2/20 0.39
HTR2A P28223 2/20 0.39
SLC6A4 P31645 2/20 0.39
HRH1 P35367 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 2/20 0.39
HRH3 Q9Y5N1 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2279691 0.89 AOC3 (0.42) AOC3BRD4LMNASMN1; SMN2OPRM1
SCHEMBL2277962 0.82 AOC3 (0.42) AOC3LMNASMN1; SMN2OPRM1CHRM2
SCHEMBL9613800 0.81 AOC3 (0.44) AOC3OPRM1SLC6A2SLC6A4SLC6A3
SCHEMBL188906 0.81 CHRNB2 (0.38) AOC3SMN1; SMN2TSHRL3MBTL1OPRK1
SCHEMBL6112111 0.81 AOC3 (0.44) AOC3LMNASMN1; SMN2OPRM1SLC6A4
SCHEMBL11298724 0.80 OPRM1 (0.46) AOC3OPRM1SLC6A2SLC6A4
SCHEMBL12071516 0.80 CHRNB2 (0.56) AOC3LMNAOPRM1CHRM2SLC6A2
SCHEMBL5398515 0.80 CHRNB2 (0.56) AOC3LMNAOPRM1CHRM2SLC6A2
SCHEMBL9995387 0.80 CHRNB2 (0.56) AOC3LMNAOPRM1CHRM2SLC6A2
SCHEMBL28144244 0.80 CHRNB2 (0.56) AOC3LMNAOPRM1CHRM2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008081477-A1 3-ARYLOXY 3-SUBSTITUTED PROPANAMINES NATCO PHARMA LIMITED (IN) 2008-07-10 WO disclosed